Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:AKZA - NL0013267909 - Common Stock

59.16 EUR
-0.56 (-0.94%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

4

AKZA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. There are concerns on the financial health of AKZA while its profitability can be described as average. AKZA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AKZA had positive earnings in the past year.
  • AKZA had a positive operating cash flow in the past year.
  • In the past 5 years AKZA has always been profitable.
  • AKZA had a positive operating cash flow in each of the past 5 years.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • AKZA's Return On Assets of 0.42% is in line compared to the rest of the industry. AKZA outperforms 43.48% of its industry peers.
  • Looking at the Return On Equity, with a value of 1.48%, AKZA is in line with its industry, outperforming 49.28% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.70%, AKZA is in line with its industry, outperforming 52.17% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AKZA is in line with the industry average of 6.95%.
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROIC 3.7%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • AKZA has a Profit Margin (0.56%) which is comparable to the rest of the industry.
  • AKZA's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 4.84%, AKZA is in line with its industry, outperforming 52.17% of the companies in the same industry.
  • AKZA's Operating Margin has been stable in the last couple of years.
  • AKZA's Gross Margin of 39.78% is in line compared to the rest of the industry. AKZA outperforms 55.07% of its industry peers.
  • In the last couple of years the Gross Margin of AKZA has remained more or less at the same level.
Industry RankSector Rank
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKZA is destroying value.
  • Compared to 1 year ago, AKZA has about the same amount of shares outstanding.
  • The number of shares outstanding for AKZA has been reduced compared to 5 years ago.
  • The debt/assets ratio for AKZA has been reduced compared to a year ago.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.07 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AKZA has a Altman-Z score of 2.07. This is in the lower half of the industry: AKZA underperforms 62.32% of its industry peers.
  • AKZA has a debt to FCF ratio of 10.17. This is a negative value and a sign of low solvency as AKZA would need 10.17 years to pay back of all of its debts.
  • AKZA has a Debt to FCF ratio (10.17) which is in line with its industry peers.
  • AKZA has a Debt/Equity ratio of 0.93. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
  • AKZA has a Debt to Equity ratio of 0.93. This is in the lower half of the industry: AKZA underperforms 76.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Altman-Z 2.07
ROIC/WACC0.63
WACC5.84%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • AKZA has a Current Ratio of 1.25. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
  • AKZA's Current ratio of 1.25 is on the low side compared to the rest of the industry. AKZA is outperformed by 78.26% of its industry peers.
  • AKZA has a Quick Ratio of 1.25. This is a bad value and indicates that AKZA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.92, AKZA is doing worse than 60.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.92
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

  • The earnings per share for AKZA have decreased by -2.93% in the last year.
  • The Earnings Per Share has been growing slightly by 4.44% on average over the past years.
  • Looking at the last year, AKZA shows a decrease in Revenue. The Revenue has decreased by -2.03% in the last year.
  • AKZA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.92% yearly.
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.81% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.75% on average over the next years.
EPS Next Y3.31%
EPS Next 2Y8.12%
EPS Next 3Y8.87%
EPS Next 5Y8.81%
Revenue Next Year-3.31%
Revenue Next 2Y-2.08%
Revenue Next 3Y0.46%
Revenue Next 5Y3.75%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.25, which indicates a correct valuation of AKZA.
  • 78.26% of the companies in the same industry are more expensive than AKZA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of AKZA to the average of the S&P500 Index (27.47), we can say AKZA is valued slightly cheaper.
  • AKZA is valuated correctly with a Price/Forward Earnings ratio of 13.01.
  • Based on the Price/Forward Earnings ratio, AKZA is valued a bit cheaper than the industry average as 79.71% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of AKZA to the average of the S&P500 Index (24.26), we can say AKZA is valued slightly cheaper.
Industry RankSector Rank
PE 16.25
Fwd PE 13.01
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • AKZA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AKZA is more expensive than 63.77% of the companies in the same industry.
  • AKZA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKZA is cheaper than 73.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.24
EV/EBITDA 16.22
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.91
PEG (5Y)3.66
EPS Next 2Y8.12%
EPS Next 3Y8.87%

3

5. Dividend

5.1 Amount

  • AKZA has a Yearly Dividend Yield of 3.40%.
  • AKZA's Dividend Yield is a higher than the industry average which is at 2.45.
  • Compared to an average S&P500 Dividend Yield of 1.89, AKZA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.4%

5.2 History

  • The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • 691.38% of the earnings are spent on dividend by AKZA. This is not a sustainable payout ratio.
DP691.38%
EPS Next 2Y8.12%
EPS Next 3Y8.87%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (1/16/2026, 7:00:00 PM)

59.16

-0.56 (-0.94%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-22
Earnings (Next)02-03
Inst Owners73.9%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap10.12B
Revenue(TTM)10.40B
Net Income(TTM)58.00M
Analysts74.78
Price Target70.25 (18.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.4%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP691.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.89%
Min EPS beat(2)-7.4%
Max EPS beat(2)-6.38%
EPS beat(4)0
Avg EPS beat(4)-11.39%
Min EPS beat(4)-27.6%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-8.1%
EPS beat(12)2
Avg EPS beat(12)-11.74%
EPS beat(16)4
Avg EPS beat(16)-11.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.57%
PT rev (1m)0.36%
PT rev (3m)-1.61%
EPS NQ rev (1m)-17.86%
EPS NQ rev (3m)-14.33%
EPS NY rev (1m)-1.03%
EPS NY rev (3m)-5.35%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-2.15%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 16.25
Fwd PE 13.01
P/S 0.97
P/FCF 19.24
P/OCF 11.92
P/B 2.57
P/tB 69.31
EV/EBITDA 16.22
EPS(TTM)3.64
EY6.15%
EPS(NY)4.55
Fwd EY7.69%
FCF(TTM)3.08
FCFY5.2%
OCF(TTM)4.96
OCFY8.39%
SpS60.83
BVpS22.98
TBVpS0.85
PEG (NY)4.91
PEG (5Y)3.66
Graham Number43.38
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROCE 5.56%
ROIC 3.7%
ROICexc 4.33%
ROICexgc 8.48%
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
FCFM 5.06%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Debt/EBITDA 4.17
Cap/Depr 86.36%
Cap/Sales 3.1%
Interest Coverage 2.86
Cash Conversion 96.7%
Profit Quality 906.9%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 2.07
F-Score5
WACC5.84%
ROIC/WACC0.63
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
EPS Next Y3.31%
EPS Next 2Y8.12%
EPS Next 3Y8.87%
EPS Next 5Y8.81%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%
Revenue Next Year-3.31%
Revenue Next 2Y-2.08%
Revenue Next 3Y0.46%
Revenue Next 5Y3.75%
EBIT growth 1Y-49.8%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year30.04%
EBIT Next 3Y15.63%
EBIT Next 5Y9.36%
FCF growth 1Y-8.04%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y1.07%
OCF growth 3Y3.41%
OCF growth 5Y96.16%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


What is the valuation status for AKZA stock?

ChartMill assigns a valuation rating of 4 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


What is the profitability of AKZA stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 4 / 10.


What is the financial health of AKZO NOBEL N.V. (AKZA.AS) stock?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 3.31% in the next year.